← Leaderboards
Peter Rudd
Stanford University
$1,985,482
Attributed
$1,985,482
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $25.4K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$1,985,482 · 3
By mechanism
R01$1,867,043 · 1
M01$118,439 · 2
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- David K Stevenson$13,604,013
- William Stewart Agras$6,930,398
- Robert S Negrin$29,816,136
- Ian H. Gotlib$25,527,303
- James D Lock$21,452,769
Others in their field
Top investigators on “Warfarin”
- Marc Ivor Chimowitz · University Of Florida$28,719,234
- Dan M Roden · Vanderbilt University Medical Center$28,601,711
- Shunichi Homma · Columbia University Health Sciences$24,755,631
- Thomas L Ortel · Duke University$21,868,767
- John L Thompson · Columbia University Health Sciences$21,297,693
- Patrick M Pullicino · Univ Of Med/Dent Of Nj-Nj Medical School$18,704,777
Research focus
WarfarinClinical ResearchCost EffectivenessHuman SubjectTherapy ComplianceChemopreventionAntihypercholesterolemic AgentHealth Care Service PlanningHealth Services Research TagOral AdministrationOutcomes ResearchBehavioral /Social Science Research TagBehavior TherapyCardiovascular Disorder ChemotherapyHuman Therapy EvaluationHyperlipidemiaPatient Oriented ResearchBlood Disorder ChemotherapyProsthetic Heart ValveClinical TrialsCongestive Heart FailureOutpatient CareOxidoreductase InhibitorPatient Monitoring Device
Grant awards (7)
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$4,447
M01 · FY2006 · RR · contact PI
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$25,392
M01 · FY2005 · RR
Improving Adherence for Dyslipidemia and Anticoagulation$88,600
M01 · FY2004 · RR
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$465,144
R01 · FY2003 · HL
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$465,314
R01 · FY2002 · HL
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$471,000
R01 · FY2001 · HL
IMPROVING ADHERENCE FOR DYSLIPIDEMIA AND ANTICOAGULATION$465,585
R01 · FY2000 · HL